Biology of métastases and its clinical implications: Testicular germ-cell tumors

J. P. Donohue, Richard Foster, J. S. Little, Patrick Loehrer, Lawrence Einhorn

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This article deals with observations of the clinical behavior of metastatic germ cell cancers of testicular origin. Therefore, when we speak of biology of métastases, we refer to that seen by the clinician as opposed to the laboratory scientist. First, we will review our experience with chemotherapy for metastatic disease. From this we can gain insight into risk factors for relapse and survival. Furthermore, we can infer there are fundamental differences in the biology of germ cell cancers of testicular origin as opposed to primary mediastinal or primary retmperiioneal origin. Some of these differences are further discussed. We also identify good risk parameters and suggest criteria for expectant or conservative management postchemotherapy instead of postchemotherapy surgical management. Second, the diversity of métastases as evidenced by a wide histologie spectrum, is discussed in clinical terms. Among topics discussed are non-germ-cell malignant elements found within metastatic germ cell tumors, and possible mechanisms for their emergence. Third, the increasing awareness of long delayed, late relapse and its relative refractoriness to chemotherapy gives further insight into the clinical biology of metastatic germ cell cancer. The multipotential nature of the germ cell results in a wide variety of metastatic subtypes, each with its own clinical behavior. Therefore, a variety of clinical management strategies may be required based upon these different clinical behaviors.

Original languageEnglish
Pages (from-to)197-203
Number of pages7
JournalWorld Journal of Urology
Volume14
Issue number3
StatePublished - 1996

Fingerprint

Germ Cell and Embryonal Neoplasms
Laboratory Personnel
Recurrence
Drug Therapy
Germ Cells
Testicular Germ Cell Tumor

ASJC Scopus subject areas

  • Urology

Cite this

Biology of métastases and its clinical implications : Testicular germ-cell tumors. / Donohue, J. P.; Foster, Richard; Little, J. S.; Loehrer, Patrick; Einhorn, Lawrence.

In: World Journal of Urology, Vol. 14, No. 3, 1996, p. 197-203.

Research output: Contribution to journalArticle

@article{0a0e677e222a4c7cb0a47240c18d3224,
title = "Biology of m{\'e}tastases and its clinical implications: Testicular germ-cell tumors",
abstract = "This article deals with observations of the clinical behavior of metastatic germ cell cancers of testicular origin. Therefore, when we speak of biology of m{\'e}tastases, we refer to that seen by the clinician as opposed to the laboratory scientist. First, we will review our experience with chemotherapy for metastatic disease. From this we can gain insight into risk factors for relapse and survival. Furthermore, we can infer there are fundamental differences in the biology of germ cell cancers of testicular origin as opposed to primary mediastinal or primary retmperiioneal origin. Some of these differences are further discussed. We also identify good risk parameters and suggest criteria for expectant or conservative management postchemotherapy instead of postchemotherapy surgical management. Second, the diversity of m{\'e}tastases as evidenced by a wide histologie spectrum, is discussed in clinical terms. Among topics discussed are non-germ-cell malignant elements found within metastatic germ cell tumors, and possible mechanisms for their emergence. Third, the increasing awareness of long delayed, late relapse and its relative refractoriness to chemotherapy gives further insight into the clinical biology of metastatic germ cell cancer. The multipotential nature of the germ cell results in a wide variety of metastatic subtypes, each with its own clinical behavior. Therefore, a variety of clinical management strategies may be required based upon these different clinical behaviors.",
author = "Donohue, {J. P.} and Richard Foster and Little, {J. S.} and Patrick Loehrer and Lawrence Einhorn",
year = "1996",
language = "English",
volume = "14",
pages = "197--203",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Biology of métastases and its clinical implications

T2 - Testicular germ-cell tumors

AU - Donohue, J. P.

AU - Foster, Richard

AU - Little, J. S.

AU - Loehrer, Patrick

AU - Einhorn, Lawrence

PY - 1996

Y1 - 1996

N2 - This article deals with observations of the clinical behavior of metastatic germ cell cancers of testicular origin. Therefore, when we speak of biology of métastases, we refer to that seen by the clinician as opposed to the laboratory scientist. First, we will review our experience with chemotherapy for metastatic disease. From this we can gain insight into risk factors for relapse and survival. Furthermore, we can infer there are fundamental differences in the biology of germ cell cancers of testicular origin as opposed to primary mediastinal or primary retmperiioneal origin. Some of these differences are further discussed. We also identify good risk parameters and suggest criteria for expectant or conservative management postchemotherapy instead of postchemotherapy surgical management. Second, the diversity of métastases as evidenced by a wide histologie spectrum, is discussed in clinical terms. Among topics discussed are non-germ-cell malignant elements found within metastatic germ cell tumors, and possible mechanisms for their emergence. Third, the increasing awareness of long delayed, late relapse and its relative refractoriness to chemotherapy gives further insight into the clinical biology of metastatic germ cell cancer. The multipotential nature of the germ cell results in a wide variety of metastatic subtypes, each with its own clinical behavior. Therefore, a variety of clinical management strategies may be required based upon these different clinical behaviors.

AB - This article deals with observations of the clinical behavior of metastatic germ cell cancers of testicular origin. Therefore, when we speak of biology of métastases, we refer to that seen by the clinician as opposed to the laboratory scientist. First, we will review our experience with chemotherapy for metastatic disease. From this we can gain insight into risk factors for relapse and survival. Furthermore, we can infer there are fundamental differences in the biology of germ cell cancers of testicular origin as opposed to primary mediastinal or primary retmperiioneal origin. Some of these differences are further discussed. We also identify good risk parameters and suggest criteria for expectant or conservative management postchemotherapy instead of postchemotherapy surgical management. Second, the diversity of métastases as evidenced by a wide histologie spectrum, is discussed in clinical terms. Among topics discussed are non-germ-cell malignant elements found within metastatic germ cell tumors, and possible mechanisms for their emergence. Third, the increasing awareness of long delayed, late relapse and its relative refractoriness to chemotherapy gives further insight into the clinical biology of metastatic germ cell cancer. The multipotential nature of the germ cell results in a wide variety of metastatic subtypes, each with its own clinical behavior. Therefore, a variety of clinical management strategies may be required based upon these different clinical behaviors.

UR - http://www.scopus.com/inward/record.url?scp=0029683132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029683132&partnerID=8YFLogxK

M3 - Article

C2 - 8806199

AN - SCOPUS:0029683132

VL - 14

SP - 197

EP - 203

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 3

ER -